Literature DB >> 18679653

[Calculating the price of a new diagnostic or therapeutic option. Example of transurethral resection of bladder tumors using photodynamic diagnostics with hexaminolevulinic acid].

M Burger1, S Petschl, B G Volkmer.   

Abstract

New diagnostic or therapeutic options (NDTOs) are remunerated separately in the German DRG system. The Institute for Remuneration in Hospitals decides which proposed NDTOs are accepted for separate remuneration for 1 year. With this acceptance, hospitals can enter negotiations with insurance companies for an individual price of the NDTO. Because there are no general recommendations for these negotiations, we present a scheme for how to calculate an NDTO, based on the example of the NDTO for transurethral resection of bladder tumors using photodynamic diagnostic with hexaminolevulinic acid.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679653     DOI: 10.1007/s00120-008-1810-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  2 in total

1.  Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.

Authors:  Zachary Klaassen; Kathy Li; Wassim Kassouf; Peter C Black; Alice Dragomir; Girish S Kulkarni
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

Review 2.  Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer.

Authors:  Anna Kołodziej; Wojciech Krajewski; Michał Matuszewski; Krzysztof Tupikowski
Journal:  Cent European J Urol       Date:  2016-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.